Krystal Biotech buy Guggenheim
Start price
27.02.24
/
50%
€152.00
Target price
27.02.25
€161.18
Performance (%)
-4.51%
Price
25.04.24
€145.15
Summary
This prediction is currently active. With a performance of -4.51%, the BUY prediction for Krystal Biotech by Guggenheim is down slightly. This prediction currently runs until 27.02.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | -2.420% | -2.420% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
Comments by Guggenheim for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Guggenheim from $130.00 to $175.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat